Skip to content

PHARMACTION

Active Private limited companyfounded 2017active for 9 yearsBerthelotstraat 106, 1190 ForestKBO/BCE: BE 0671.515.855
PHARMACTION
Financial year 2025
Follow ReportCompare

Annual accounts 2025

micro format, filed on 30-11-2025, 62 days before the deadline
€28,360
▲ 26.2%
€26,973
▲ 25.0%
€19,582
▲ 23.7%
€85,463
▲ 31.7%
29.9%
▲ 5.1 percentage points
1.42
▲ 0.10

Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.

Turnover ≈ €75,000. Estimated: probably between €53,000 and €100,000.

Balance sheet

balance sheet total €290,873 on 30-06-2025
What the company ownsHow it is paid for

in euro

in euro

Position in the sector

Compare with sector

29.9%

Higher than 32% of 8,614 companies in 2025.

1.42

Higher than 37% of 8,290 companies in 2025.

6.7%

Higher than 42% of 8,399 companies in 2025.

PHARMACTION Middle half of the sector 80% of the sector Micro accounts in advertising and market research (NACE 73)

Net result: middle half · Equity: middle half · Balance sheet total: middle half · Working capital: middle half

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend20252024202320222021202020192018
Balance sheet: assets
20/58 290,873271,430175,07999,07195,11551,11533,25063,349
21/28 1,4922,492--6,00012,00018,00024,000
21 1,4922,492--6,00012,00018,00024,000
29/58 289,381268,939175,07999,07189,11539,11515,25039,349
40/41 283,465239,034161,71771,27677,95736,49513,36336,988
40 277,892236,465159,74270,76377,95736,2949,41831,805
41 5,5732,5691,975513-2013,9455,183
54/58 5,91629,90412,46227,79511,1582,6201,8872,361
490/1 --900-----
Balance sheet: equity and liabilities
10/49 290,873271,430175,07999,07195,11551,11533,25063,349
10/15 86,95467,37351,53737,77528,41119,11615,49715,167
10/11 20,40520,40518,55018,55018,55018,55018,55018,550
10 ---18,550----
100 ---18,55018,55018,55018,55018,550
13 --1,8551,855100100--
130/1 --1,8551,855100100--
130 ---1,855100100--
1311 --1,855-----
14 66,54946,96831,13217,3709,761466-3,053-3,383
17/49 203,918204,058123,54261,29666,70431,99917,75348,182
42/48 203,918204,058123,54261,12266,53031,82617,57948,008
44 188,147198,362122,95457,55661,87619,3065,45935,888
440/4 188,147198,362122,95457,55661,87619,3065,45935,888
46 8,424-------
45 7,3485,6955873,5464,634400--
450/3 7,3485,6955873,5464,634400--
47/48 ---202012,12012,12012,120
492/3 ---174174173174174
Income statement
9900 28,36022,47818,89018,91119,05110,3886,7073,482
630 1,000508-6,0006,0006,0006,0006,000
640/8 387384348348348348356848
9901 26,97321,58618,54212,56312,7034,040351-3,366
75/76B 1-0-----
75 1-0-----
65/66B 44351923724222117
65 4435192-----
66B ---3724222117
9903 26,93021,55118,35012,52612,6794,018330-3,383
67/77 7,3485,7164,5873,1633,384399--
9904 19,58215,83513,7629,3639,2953,619330-3,383
9905 19,58215,83513,7629,3639,2953,619330-3,383
Appropriation of the result
9906 66,54946,96831,13219,1259,761566-3,053-3,383
14P 46,96831,13217,3709,762----
691/2 ---1,755-100--
6920 ---1,755-100--
Document PDFPDFPDFPDFPDFPDFPDFPDF

The notes to these accounts have 5 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the filed accounts (PDF).

Source: Annual accounts 2025 (PDF), filed on 30-11-2025.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank
Financial year Type Filed Reference Document
30-06-2025 micro format 30-11-2025 2025-00576333 PDF
30-06-2024 micro format 23-01-2025 2025-00009036 PDF
30-06-2023 micro format 27-12-2023 2023-00537543 PDF
30-06-2022 micro format 13-12-2022 2022-20536244 PDF
30-06-2021 micro format 27-01-2022 2022-02500521 PDF
30-06-2020 micro format 18-02-2021 2021-05600471 PDF
30-06-2019 micro format 10-02-2020 2020-04800177 PDF
30-06-2018 micro format 12-01-2019 2019-01200470 PDF

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend20252024202320222021202020192018
27,97222,094-18,56318,70310,0406,3512,634
20,58216,343-15,36315,2959,6196,3302,617
03,000-000030,000
-23,98817,442-15,33316,6378,538733-474-
85,46364,88151,53737,94922,5857,289-2,329-8,659
29.9%24.8%29.4%38.1%29.9%37.4%46.6%23.9%
1.421.321.421.621.341.230.870.82
2.353.032.401.622.351.671.153.18
22.5%23.5%26.7%24.8%32.7%18.9%2.1%-22.3%
6.7%5.8%7.9%9.5%9.8%7.1%1.0%-5.3%
over 100over 100-over 100----

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Investments

fixed assets acquired
Item30-06-202530-06-202430-06-202330-06-2022
Intangible fixed assets-€3,000--
€1,000€508-€6,000

Source: notes to the 2022 to 2025 annual accounts (statement of fixed assets)

Insights on PHARMACTION

The operating result for 2025 is 25% higher than in 2024 and the highest since 2018. It is the third rise in a row, after the fall in 2022.

Debt's share of the balance-sheet total falls from 75.2% to 70.1%. Equity is higher and debt is lower.

Next steps

Work out how much credit to give this customer and on what payment terms.Credit check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed

We would like to set cookies. That happens only with your consent. What we measure